Plant metabolite-based immunity booster for disease resistance and longevity

Overview

This solution leverages a novel class of plant-derived bioactive metabolites that regulate immune receptor levels and confer basal priming of plant defenses. By boosting receptor levels, these metabolites lower the threshold for plants to respond to damage and microbe-associated molecular patterns, creating more robust responses to infection. The same compounds may also regulate longevity, potentially improving the lifespan of plant organs.

The technology is derived from research on an enzyme essential for both basal and systemic defense responses. While a previously known enzyme product only partially explains the full range of immune effects, the research team has identified at least one novel bioactive compound produced by this enzyme that regulates immune receptors and confers immunity when applied exogenously to naive plants.

Technical specifications

Key features:

• Novel bioactive metabolite produced by a characterized plant defense enzyme
• Mechanism: regulates immune receptor levels to lower activation thresholds for defense responses
• Exogenous application confers immunity without requiring genetic modification of crops
• Plants engineered with elevated enzyme levels show increased disease resistance
• Exudates from high-enzyme plants transfer immunity to untreated plants
• Potential dual benefit: enhanced disease resistance and improved plant organ longevity

Research approach:

• Scale-up of active exudate production from engineered plants
• Fractionation to reduce mixture complexity and isolate active components
• Bioassay-guided identification of active fractions
• Analytical characterization using GC/MS-MS and LC/MS-MS, with NMR for novel candidates
• Formulation development for direct plant treatment
• Initial work in Arabidopsis with potential extension to other species for scale-up

Technology readiness level

The technology is currently at an early-to-mid stage of development. Key validations completed include demonstrating that a major immune receptor's level and activity are regulated by the metabolite, that plants with elevated enzyme levels exhibit increased disease resistance, and that exudates confer immunity when applied to naive plants. Future work will focus on scaling up exudate production, isolating and identifying the active molecular candidates, and developing formulations suitable for direct plant treatment to achieve protection from infection and test longevity effects. The technology is ready for collaborative development toward agricultural applications.